Jarlega, Angel D.
HRN: 26-51-80 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2025
CEFTRIAXONE 1G (VIAL)
01/14/2025
01/21/2025
IV
1g
Q12
Fracture
Waiting Final Action